Advances with the discovery and development of novel sigma 1 receptor antagonists for the management of pain-Reference-Cited by-同舟云学术

Advances with the discovery and development of novel sigma 1 receptor antagonists for the management of pain

Published:2023-05-26 Issue:7 Volume:18 Page:693-705
ISSN:1746-0441
Container-title:Expert Opinion on Drug Discovery
language:en
Short-container-title:Expert Opinion on Drug Discovery

Author:

Burns Mallory¹,Guadagnoli Nicholas¹,McCurdy Christopher R.¹²^ORCID

Affiliation:

1. Department of Medicinal Chemistry, College of Pharmacy, University of Florida, Gainesville, FL, USA

2. Clinical and Translational Sciences Institute, Translational Drug Development Core, University of Florida, Gainesville, FL, USA

Funder

University of Florida

Publisher

Informa UK Limited

Subject

Drug Discovery

Link

https://www.tandfonline.com/doi/pdf/10.1080/17460441.2023.2216015

Reference117 articles.

1. Revisions to the IASP definition of pain—What does this mean for children?

2. The definition of pain

3. National pain strategy: a comprehensive population health-level strategy for pain. NIH. 2015. https://www.iprcc.nih.gov/national-pain-strategy-overview

4. Pharmacologic Management of Chronic Pain

5. Chronic pain: an update on burden, best practices, and new advances

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Developments in Sigma-2 Receptor Compounds for Pain;Cureus;2024-05-08

2. Bispecific Sigma1R-Antagonist/MOR-Agonist Compounds for Pain;Cureus;2024-05-07

3. IUPHAR Review - Bivalent and bifunctional opioid receptor ligands as novel analgesics;Pharmacological Research;2023-11

4. Genetic and Pharmacological Blockade of Sigma-1 Receptors Attenuates Inflammation-Associated Hypersensitivity during Acute Colitis in CD1 Mice;Biomedicines;2023-10-12